Retinal Degeneration Fund
Raleigh, North Carolinaretinaldegenerationfund.org
Overview
The Retinal Degeneration Fund (RD Fund) is the venture philanthropy arm of the Foundation Fighting Blindness, making mission-related investments in companies developing treatments and cures for inherited retinal diseases and dry age-related macular degeneration.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Beacon Therapeutics | Jan 2026 | Series C | Co-investor |
| Perceive Pharma | Feb 2025 | Series A | Co-investor |
| Perceive Bio | Jan 2023 | Series B | - |
| SparingVision | Sep 2022 | Series B | Co-investor |
| Nacuity Pharmaceuticals, Inc. | Jun 2022 | Series B | - |
Key People
Maureen Okereke
Chief Executive Officer
Rusty Kelley
Managing Director, Senior Vice President, Investments And Alliances
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
